Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Pharmacokinetic Study of Single Doses of Sativex in Treatment-induced Mucositis

This study has been terminated.
(Slow recruitment)
Sponsor:
Information provided by (Responsible Party):
GW Pharmaceuticals Ltd.
ClinicalTrials.gov Identifier:
NCT01975688
First received: October 29, 2013
Last updated: August 10, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2015
  Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)